Does MTRR regenerate methylcobalamin for methionine synthase?

The methionine-homocysteine cycle relies on a highly coordinated network of enzymes and cofactors to maintain cellular methylation capacity and regulate homocysteine levels.

Biochemical mechanisms of cofactor regeneration

• The oxidation bottleneck: Methionine synthase (MTR) catalyzes the transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine, a reaction dependent on the active cofactor methylcobalamin (MeCbl). During this cycle, the highly reactive, supernucleophilic cob(I)alamin intermediate occasionally undergoes spontaneous oxidation into inactive cob(II)alamin, rendering the MTR enzyme catalytically inert.
• MTRR-mediated reactivation: To restore enzyme activity, methionine synthase reductase (MTRR) acts as a crucial dual-flavoprotein redox partner. Utilizing electrons from NADPH, MTRR transfers reducing equivalents through its FAD and FMN domains to perform a one-electron reduction of cob(II)alamin back to the transient cob(I)alamin state.
• SAM-dependent methylation: Once reduced to cob(I)alamin, S-adenosylmethionine (SAM) acts as the immediate methyl donor, methylating the intermediate to regenerate active, enzyme-bound MeCbl so the remethylation of homocysteine can resume.

Clinical and genetic implications

• Genetic variants: Polymorphisms in the MTRR gene, most notably the common rs1801394 (A66G) variant, decrease the binding efficiency and reactivation rate of MTRR. This molecular impairment traps MTR in its inactive state, reducing steady-state methylcobalamin levels and leading to elevated systemic homocysteine.

Bottom line

• MTRR is biochemically essential for reducing oxidized cob(II)alamin and, alongside SAM, regenerating the active methylcobalamin cofactor required by methionine synthase to convert homocysteine to methionine.